The rare monogenic arrhythmogenic disorder catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterised by episodic ventricular dysrhythmia triggered by exercise or emotion in individuals without structural cardiac defects. Next generation sequencing has now become more widely accessible and RYR2 in its entirety can be screened relatively easily. This has led to an increase in the number of RYR2 variants being reported in individuals with cardiac dysrhythmia. The majority of RYR2 variants are missense changes that lead to increased channel activity and the rarity of these variants makes it difficult to determine their pathogenicity, thus the majority are classified as being of unknown significance (VUS). We collated RYR2 variants reported in individuals with or suspected of having CPVT and classified them using a statistical method and the ACMG guidelines. Where possible the phenotype associated with each variant was recorded to determine any genotype-phenotype correlations. Recently RYR2 variants have also been shown to cause ventricular arrhythmias by a loss of function mechanism. We used five computational splice prediction tools and an ex vivo splicing assay to investigate whether 329 rare variants in RYR2 from a cohort of individuals undergoing genetic testing for a ventricular arrhythmia alter splicing. Ten RYR2 variants were predicted to disrupt splicing by multiple computational tools. Of these, none altered splicing in an ex vivo splicing assay.
44/Characterisation of missense variants in RYR2
Share this Article
Related Content In Arrhythmia
Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock and Hyperkalemia Syndrome Involving Digoxin Toxicity: A Case Report
Heart International. 2023;17(1):Online ahead of journal publication
Bradycardia, renal failure, atrioventricular nodal blockade, shock and hyperkalemia (BRASH) syndrome is a rare, often unrecognized but potentially life-threatening clinical entity that is characterized by the pentad of symptoms after which it is named. BRASH syndrome is seen most commonly in the setting of atrioventricular nodal-blocking medications such as beta-blockers and calcium channel blockers.1,2 The synergistic interplay of […]
Radiofrequency Lesion Quality Markers: Current State of Knowledge
European Journal of Arrhythmia & Electrophysiology. 2022;8(1):2-6 DOI: https://doi.org/10.17925/EJAE.2022.8.1.2
Radiofrequency (RF) ablation involves delivering medium-to-high-frequency alternating current, which is electrically conducted to cardiac tissue that constitutes a part of the circuit. The unipolar circuitry contains the generator, transmission lines, catheter, cardiac tissue, interposed tissue and dispersive electrode (ground pad/indifferent electrode). Bipolar systems, whereby the RF current flows between two electrodes, either on the same […]
Remote Monitoring of Cardiac Arrhythmias Using Wearable Digital Technology: Paradigm Shift or Pipe Dream?
European Journal of Arrhythmia & Electrophysiology. 2022;8(1):7-12 DOI: https://doi.org/10.17925/EJAE.2022.8.1.7
Several smart, connected and direct-to-consumer wearable devices capable of detecting cardiac arrhythmias have proliferated in the marketplace in the last decade. Increasingly, these devices are being marketed as “medical grade” in addition to “wellness” devices.1 New iterations of smartwatch and smartphone technology incorporate biosensors and advanced artificial intelligence (AI) algorithms equipped to diagnose cardiac arrhythmias; examples […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!